Clinical trials
AKI clinical trials
Below are recruiting aki clinical trials, each written for real people, not researchers. We’re tracking 46 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07106151Recruiting
Recovering from kidney failure after dialysis in hospital
This study looks at how patients recover from acute kidney injury that needs dialysis after they leave the hospital. It aims to understand and improve care during the transition to outpatient dialysis.
San Francisco, CaliforniaAges 18 years+ - NCT07581184RecruitingPhase 1
Targeted Radioactive Therapy for Advanced Prostate Cancer
This Phase 1 trial tests a new radioactive treatment called [225Ac]Ac-AKY-2519 in men with advanced prostate cancer that has spread and stopped responding to hormone therapy. The drug carries radioactivity directly to cancer cells to try to shrink tumors and slow disease progression.
Irvine, CaliforniaAges 18 years+ - NCT07020117RecruitingPhase 1
Study of AKY-1189 for advanced solid tumors
This trial tests a new radioactive drug, AKY-1189, for people with solid tumors that have spread or cannot be removed. It may help if other treatments have stopped working.
Duarte, CaliforniaAges 18 years+ - NCT06917053Recruiting
Ultrasound to predict kidney injury after trauma
This study tests whether a special ultrasound with contrast agent can help predict if you might develop acute kidney injury after a serious trauma. It focuses on patients in the ICU who have had a major injury and received blood products.
LondonAges 18 years+ - NCT07222722Recruiting
Brain oxygen monitoring for preterm babies and kidney health
This trial uses a special monitor to check oxygen levels in the brain of very premature babies. It aims to see if low oxygen affects kidney health.
New York, New YorkAges 6 months–7 months - NCT04216927RecruitingPhase 3
Neonates on heart-lung bypass get NO to prevent kidney injury
This Phase 3 study tests whether not giving nitric oxide during heart-lung bypass in newborns helps reduce the risk of acute kidney injury. It focuses on newborns having heart surgery for congenital heart disease.
Cincinnati, OhioAges 1 day–1 month - NCT05147831Recruiting
Remote arm treatment to prevent kidney injury from contrast dye
This trial tests whether a simple “arm conditioning” technique done remotely before a procedure can help prevent kidney injury caused by contrast dye used during certain heart catheter tests. You might benefit if you’re having a coronary angiogram and your kidney function is reduced, but you’re not on dialysis.
Galveston, TexasAges 18 years+ - NCT04404114Recruiting
Shear wave ultrasound to tell acute from chronic kidney disease
This study checks whether a special ultrasound can help tell whether kidney problems started suddenly (acute) or have been present longer (chronic). It may help doctors choose the right next steps faster in the emergency room.
TaipeiAges 20 years+ - NCT05730816RecruitingPhase 2
Magnesium to help protect kidneys during high-risk chest surgery
This Phase 2 trial studies whether giving magnesium by IV can help prevent sudden kidney injury around the time of certain major chest (thoracic) cancer surgeries. If you qualify, you may receive magnesium or a comparison treatment to see if kidney protection improves after surgery.
Boston, MassachusettsAges 18 years+ - NCT05988658Recruiting
Using scores and biomarkers to predict kidney injury in hospital patients
This study uses a risk score and blood tests to predict which hospitalized patients might develop acute kidney injury (sudden kidney damage). If you are at high risk, researchers will follow you closely to see if early detection can help prevent serious kidney problems.
Chicago, IllinoisAges 18 years+ - NCT06685367Recruiting
AI software for predicting acute kidney injury in ICU
This trial tests software that uses artificial intelligence to predict if a patient in the ICU might develop acute kidney injury (sudden kidney damage). It aims to see if the software is cost-effective and could help doctors catch problems earlier.
TaichungAges 20 years+ - NCT05805709Recruiting
COPE-AKI: A care plan for people hospitalized with serious AKI
This trial tests a patient-centered plan for how care is organized and communicated for people hospitalized with serious, persistent kidney injury (AKI). The goal is to improve the experience and possibly outcomes by making care more consistent and easier to follow.
Birmingham, AlabamaAges 18 years+ - NCT07749417Recruiting
Detecting kidney injury early after heart procedures
This study tests a new light-based method to check kidney function right after heart surgery or imaging tests that use contrast dye. It aims to catch kidney damage early, so doctors can treat it sooner.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06496555Recruiting
Predicting kidney injury in ICU patients
This study tests a tool called U-AKIpredTM to see if it can predict whether a critically ill patient will develop acute kidney injury within the first 12 hours in the ICU. If you are in the ICU and have not had kidney problems before, this trial may help improve your care.
Hangzhou, ZhejiangAges 18 years+ - NCT07030179Recruiting
Frailty, kidney injury, and blood pressure in non-cardiac surgery
This study looks at whether a patient's level of frailty (overall weakness and health before surgery) affects their risk of acute kidney injury after non-cardiac surgery, and whether blood pressure changes during surgery play a role in that link.
Nanjing, JiangsuAges 18 years+ - NCT04033224Recruiting
Blood-filter treatments for ICU patients with kidney and organ failure
This trial tests a specific type of blood-filter treatment in critically ill ICU patients who have acute kidney injury and/or failure of other organs. It aims to see whether these filters can improve care by supporting kidney function and/or calming harmful inflammation.
Empoli, FirenzeAges Any age - NCT04279457RecruitingPhase 4
Test whether special dye helps protect kidney function during heart procedures
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
Charleston, West VirginiaAges 18–90 - NCT05346393Recruiting
TIPS procedure for kidney failure in people with cirrhosis
This trial studies whether a liver procedure called TIPS can help people with cirrhosis who develop sudden kidney failure (HRS-AKI). It aims to improve kidney function and overall outcomes, but participation depends on several safety checks.
AachenAges 18–80 - NCT05399537RecruitingPhase 3
Testing citrate fluid safety during kidney filtration (CRRT)
This Phase 3 study checks whether Prismocitrate 18 is safe for adults who need a kidney filtration treatment called CRRT. It is mainly for people who cannot safely use heparin (a common blood thinner) due to bleeding risk.
Birmingham, AlabamaAges 18 years+ - NCT05855954Recruiting
Early kidney protection during heart surgery
This trial looks at whether a specific heart-surgery technique (called CLCVP) can help protect kidney function soon after surgery. It is mainly for adults with otherwise normal kidney tests before certain types of heart operations.
Nanjing, JiangsuAges 18 years+ - NCT05879432RecruitingPhase 2
Peptide treatment to prevent or lessen kidney injury after heart surgery
This Phase 2 trial tests an LSALT peptide given around the time of “on-pump” heart surgery to help prevent or reduce acute kidney injury (a sudden drop in kidney function). It may help people who are at higher risk for kidney injury during or after surgery.
Calgary, AlbertaAges 18 years+ - NCT05906758RecruitingPhase 3
Test ultra-low contrast heart imaging in kidney injury
This trial tests whether using a much smaller amount of contrast dye for an invasive heart scan is safer for people with acute kidney injury (AKI). It may help reduce further kidney stress while still allowing doctors to look at coronary (heart) arteries.
New Orleans, LouisianaAges 18–100 - NCT06180551Recruiting
Early kidney injury detection study in the ICU
This study tests a new way to diagnose acute kidney injury (sudden kidney damage) early in intensive care patients. It may help doctors catch kidney problems sooner and improve care.
Homburg, SaarlandAges 18 years+ - NCT06259760Recruiting
Kidney risk after low-blood-pressure anesthesia for jaw surgery
This study looks at factors that may increase the risk of kidney injury during jaw surgery when a special low-blood-pressure anesthesia technique is used. It helps doctors understand who is more likely to have complications.
Kaohsiung City, Sanmin DistAges 18–65
Hear when a new AKI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for aki?
- Yes. Clin2 currently lists 46 recruiting aki studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a aki trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a aki trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.